GSK plc (GSK)
NYSE: GSK · Real-Time Price · USD
50.99
+0.09 (0.18%)
At close: May 13, 2026, 4:00 PM EDT
51.00
+0.01 (0.02%)
After-hours: May 13, 2026, 6:14 PM EDT

GSK Income Statement

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
32,78032,66731,37630,32829,32424,696
Revenue Growth (YoY)
3.97%4.12%3.46%3.42%18.74%1.40%
Cost of Revenue
8,9559,0179,0488,5659,5548,163
Gross Profit
23,82523,65022,32821,76319,77016,533
Selling, General & Admin
9,1379,08811,0159,3858,3727,070
Research & Development
7,7557,5256,4016,2235,4885,019
Other Operating Expenses
-1,076-895891-590-52387
Total Operating Expenses
15,81615,71818,30715,01813,33712,176
Operating Income
8,0097,9324,0216,7456,4334,357
Interest Income
1371691221157614
Interest Expense
-706-701-669-792-879-769
Other Non-Operating Income (Expense)
-313-4-2-3
Total Non-Operating Income (Expense)
-572-531-544-681-805-758
Pretax Income
7,4377,4013,4776,0645,6283,599
Provision for Income Taxes
1,0811,11252675670783
Net Income
5,8295,7162,5754,92814,9564,385
Minority Interest in Earnings
527573376380665711
Earnings From Discontinued Operations
----10,7001,580
Net Income to Common
5,8295,7162,5754,92814,9564,385
Net Income Growth
84.87%121.98%-47.75%-67.05%241.07%-23.73%
Shares Outstanding (Basic)
2,0172,0262,0392,0262,0132,002
Shares Outstanding (Diluted)
2,0472,0592,0712,0562,0422,026
Shares Change (YoY)
-1.05%-0.60%0.75%0.66%0.79%0.55%
EPS (Basic)
2.892.821.262.437.432.19
EPS (Diluted)
2.852.781.242.407.322.16
EPS Growth
86.39%123.15%-48.12%-67.26%238.45%-24.12%
Shares Outstanding
2,0102,0062,0412,0282,1562,155
Free Cash Flow
6,3766,3935,1555,4546,2607,002
Free Cash Flow Growth
-0.27%24.02%-5.48%-12.88%-10.60%-6.04%
Free Cash Flow Per Share
3.123.112.492.653.073.46
Dividends Per Share
0.6700.6600.6100.5800.6131.000
Dividend Growth
1.52%8.20%5.17%-5.31%-38.75%-
Gross Margin
72.68%72.40%71.16%71.76%67.42%66.95%
Operating Margin
24.43%24.28%12.82%22.24%21.94%17.64%
Profit Margin
19.39%19.25%9.41%17.50%16.78%14.24%
FCF Margin
19.45%19.57%16.43%17.98%21.35%28.35%
EBITDA
8,00910,2466,5729,0398,5806,479
EBITDA Margin
24.43%31.36%20.95%29.80%29.26%26.24%
EBIT
8,0097,9324,0216,7456,4334,357
EBIT Margin
24.43%24.28%12.82%22.24%21.94%17.64%
Effective Tax Rate
14.54%15.02%15.13%12.47%12.56%2.31%
Updated Apr 29, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q